Respiratory disease. Chronic lower respiratory diseases,Diseases of the respiratory system,Other diseases of upper respiratory tract,Other diseases of pleura
Conditions
Interventions
Intervention 1: interventional group receives two 300mg gabapentin capsules on the night before operation and two more an hour before surgery. Intervention 2: The control group receives two placebo ca
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: between 18 and 65 years proper physical condition for VATS surgery
Exclusion criteria
Exclusion criteria: gabapentin allergy renal failure hepatic failure nervous and mental disorders history of cardiovascular surgeries pregnant and breastfeeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain assessment. Timepoint: each 30 minutes and then 2, 4, 6, 10 and 24 hours after operation. Method of measurement: VAS technique.;Opioid rate of consumption. Timepoint: up to 24 hours after operation. Method of measurement: Based on nursing chart.;Ketorolac rate of consumption. Timepoint: up to 24 hours after operation. Method of measurement: Based on nursing chart.;First analgesic need time. Timepoint: first analgesic need time after surgery. Method of measurement: Based on nursing chart. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions. Timepoint: up to 24 hours after operation. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehrooz Farzanegan
Masih Daneshvari Hospital
Outcome results
None listed